What Happened?
, -based Solid Biosciences Appointed Kevin Tan as Chief Financial Officer
About the Company
Solid Biosciences (Solid) is a life science company singularly focused on solving Duchenne muscular dystrophy (Duchenne). We aim to be the center of excellence across the entire disease spectrum, serving as a catalyst to bring together those with the expertise in science, technology, disease management and care. Disease-focused and founded by a family directly impacted, our mandate is simple yet comprehensive - attack the roots of the disease and improve daily life for patients. Solid is headquartered in Cambridge, MA, USA.
About the Person
Kevin Tan is Chief Financial Officer at Solid Biosciences. Previously, Kevin held various senior HR leadership roles in the industry.
Info Source
News
Short Profile